Although various proinflammatory and anti-inflammatory molecules can regulate synaptic plasticity in MS [39], we focused on the proinflammatory cytokine IL-1β which has been previously identified as one of the main determinants of the inflammatory synaptopathy in MS [40]. Here, IL1B is linked to myeloid sarcoma.